staurosporine has been researched along with Bright Disease in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Daver, NG; Glass, WF; Kala, J; Pankow, JD; Richard-Carpentier, G | 1 |
| Gilbert, L; Karvonen, K; Naides, SJ; Nykky, J; Pirttinen, H; Puttaraksa, K | 1 |
2 other study(ies) available for staurosporine and Bright Disease
| Article | Year |
|---|---|
Unique case of ANCA-negative pauci-immune necrotizing glomerulonephritis with diffuse alveolar hemorrhage, potentially associated with midostaurin.
Topics: Acute Kidney Injury; Administration, Intravenous; Antibodies, Antineutrophil Cytoplasmic; Biopsy; Combined Modality Therapy; Cyclophosphamide; Glomerulonephritis; Glucocorticoids; Hemorrhage; Humans; Immunosuppressive Agents; Leukemia, Myeloid, Acute; Lung Diseases; Methylprednisolone; Middle Aged; Necrosis; Plasma Exchange; Protein Kinase Inhibitors; Renal Dialysis; Staurosporine; Treatment Outcome | 2020 |
Parvovirus B19V Nonstructural Protein NS1 Induces Double-Stranded Deoxyribonucleic Acid Autoantibodies and End-Organ Damage in Nonautoimmune Mice.
Topics: Animals; Antibodies, Antinuclear; Apoptosis; Autoimmunity; Brain; DNA; Enzyme Inhibitors; Extracellular Vesicles; Female; Glomerulonephritis; Immunosuppressive Agents; Kidney Glomerulus; Liver; Mice; Myocardium; Parvovirus B19, Human; Staurosporine; Terpenes; Viral Nonstructural Proteins | 2019 |